This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Performance and Safety of Joline® Kyphoplasty Single Balloon Catheter Allevo vs. Quattroplasty Double-Balloon Catheter Stop'n GO With BonOs® Inject Bone Cement

Sponsored by University Hospital Tuebingen

About this trial

Last updated 5 years ago

Study ID

JO-2020Kypho

Status

Unknown status

Type

Observational

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 4 years ago

What is this trial about?

The purpose of this study is to assess the performance and safety of two balloon kyphoplasty systems (Joline®), the single balloon catheter Allevo and Quattroplasty double balloon catheter Stop'n Go, using BonOs® Inject bone cement for treatment of Vertebral Compression Fractures.

What are the participation requirements?

Yes

Inclusion Criteria

- patients aged ≥18 years

- 1-3 painful VCF(s), of which at least 1 meets the following criteria:

- VCF between T7 and L5
- Fracture age <3 months
- VCF shows hyperintense signal on STIR or T2 sequence MRI.

- Investigator estimates that target VB(s) is/ are suitable for Quattroplasty double balloon catheter or Kyphoplasty single balloon catheter (e.g. appropriate pedicle diameter, no cortical bone protruding into the spinal canal).

- Patient has an ODI score of 30% or more.

- Patient is willing and able to comply with study requirements.

- Patient signs informed consent form.

- Women who are post-menopausal, surgically sterile or on contraceptives and agree to remain on contraceptives for the duration of their study participation and agree not to become pregnant during the study.

No

Exclusion Criteria

- Segmental kyphosis of target VB of >30°

- Pre-existing or clinically unstable neurologic deficit

- Any physical exam evidence of myelopathy or radiculopathy

- Not able to walk without assistance prior to fractures

- Any radiographic evidence of pedicle fracture or interspinous-process widening

- Spondylolisthesis >grade 1 at target VB(s)

- History of spine surgery, including prior vertebral augmentation, during the last year

- Any underlying systemic bone disease other than osteoporosis (e.g. osteomalacia, osteogenesis imperfect, etc.)

- Irreversible coagulopathy and/or taking peri-operatively warfarin (Coumadin) or other anticoagulant

- Pregnancy and nursing

- Pain due to any other condition that requires daily narcotic medication

- Disabling back pain due to causes other than acute fracture

- History of intolerance, or allergic reaction to titanium or acrylic compounds

- Active systemic or local infection at baseline

- Severe cardiopulmonary disease (e.g. stage IV heart failure, severe chronic obstructive pulmonary disease)

- Any other medical illness or condition that, in the investigator's opinion, is likely to impair long-term follow-up (e.g. cancer) or greatly increase the risk of surgery

- Any evidence of substance abuse

- The patient is on long-term steroid therapy (steroid dose 30 mg/day for >3 months)

- The patient is known to be involved in medical litigation including Workmen's compensation.

- Patient with contraindication for MRI including but not limited to patients with contraindications for general anesthesia (surgeon expertise)

- Patient who is contraindicated for the use of PMMA cement

- Patients who belong to a vulnerable population or that are not able to sign the informed consent form.

- Patients where the VCF was treated in combination with fusion.

- Patients with any contraindication according to the IFU

Locations

Location

Status

Recruiting